Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 885,644 |
|
|||||
| News | - | ||||||
| Day High | 5.38 | Low High |
|||||
| Day Low | 4.95 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| AbSci Corporation | ABSI | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.27 | -5.10% | 5.02 | 15:30:20 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 5.28 | 4.95 | 5.38 | 5.29 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 8,661 | 885,644 | $ 5.22 | $ 4,620,070 | - | 1.1111 - 6.72 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:30:20 | 14 | $ 5.02 | USD |
AbSci Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 472.13M | 92.94M | - | 5.72M | -110.57M | -1.19 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
AbSci News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ABSI Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 6.12 | 6.27 | 4.95 | 5.59 | 1,269,000 | -1.10 | -17.97% |
| 1 Month | 5.24 | 6.72 | 4.87 | 5.62 | 1,435,767 | -0.22 | -4.20% |
| 3 Months | 3.56 | 6.72 | 3.39 | 5.00 | 1,601,306 | 1.46 | 41.01% |
| 6 Months | 1.45 | 6.72 | 1.1111 | 4.24 | 1,249,203 | 3.57 | 246.21% |
| 1 Year | 1.84 | 6.72 | 1.1111 | 3.45 | 897,500 | 3.18 | 172.83% |
| 3 Years | 21.00 | 31.5301 | 1.1111 | 5.15 | 689,965 | -15.98 | -76.10% |
| 5 Years | 21.00 | 31.5301 | 1.1111 | 5.15 | 689,965 | -15.98 | -76.10% |
AbSci Description
| Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. |
